drugset / Trial / NCT00552760

Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder

NCT00552760

Phase 4 Completed 90 enrolled Lehigh Valley Hospital Takeda · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether treating sleep difficulties in patients with bipolar disorder also improves their mood stability.

Timeline

Start
2007-11
Primary completion
2010-03
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral

Indications